{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:31:49Z","timestamp":1761975109098},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.jpeds.2009.05.033","type":"journal-article","created":{"date-parts":[[2009,11,16]],"date-time":"2009-11-16T04:30:57Z","timestamp":1258345857000},"page":"940-941","source":"Crossref","is-referenced-by-count":16,"title":["Effective Desensitization to Imiglucerase in a Patient with Type I Gaucher Disease"],"prefix":"10.1016","volume":"155","author":[{"given":"Diego G.","family":"Peroni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Pescollderungg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio L.","family":"Piacentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walburga","family":"Cassar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attilio L.","family":"Boner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2009.05.033_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2009.05.033_bib2","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3635","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"key":"10.1016\/j.jpeds.2009.05.033_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpedi.160.6.603","article-title":"The clinical and demographic characteristics of non-neuronopathic Gaucher disease in 887 children at diagnosis","volume":"160","author":"Kaplan","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jpeds.2009.05.033_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.jpeds.2009.05.033_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1359\/jbmr.061004","article-title":"Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease","volume":"22","author":"Wenstrup","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jpeds.2009.05.033_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ymgme.2006.09.003","article-title":"The long-term international safety experience of imiglucerase therapy for Gaucher disease","volume":"90","author":"Starzyk","year":"2007","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jpeds.2009.05.033_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S1079-9796(03)00012-3","article-title":"Enzyme therapy of Gaucher disease: clinical and biochemical changes during production of and tolerization for neutralizing antibodies","volume":"30","author":"Zhao","year":"2003","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jpeds.2009.05.033_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jpeds.2007.02.057","article-title":"Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease","volume":"151","author":"Drelichman","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2009.05.033_bib9","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jaci.2007.01.022","article-title":"Mechanisms of allergen-specific immunotherapy","volume":"119","author":"Akdis","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jpeds.2009.05.033_bib10","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1046\/j.1365-2222.2003.01765.x","article-title":"Induction of \u2032blocking\u2032 IgG antibodies during immunotherapy","volume":"33","author":"Wachholz","year":"2003","journal-title":"Clin Exp Allergy"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347609005393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347609005393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T04:51:17Z","timestamp":1544849477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347609005393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0022347609005393"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2009.05.033","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}